ANKE BIO released its performance for the first three quarters, with a net profit attributable to the parent company of 551 million yuan, a decrease of 6.48%
According to the Zhitong Finance APP, ANKE BIO released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.963 billion yuan, a year-on-year increase of 2.15%. The net profit attributable to shareholders of the listed company was 551 million yuan, a year-on-year decrease of 6.48%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 519 million yuan, a year-on-year decrease of 6.56%. The basic earnings per share were 0.3297 yuan
According to the Zhitong Finance APP, ANKE BIO (300009.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.963 billion yuan, a year-on-year increase of 2.15%. The net profit attributable to shareholders of the listed company was 551 million yuan, a year-on-year decrease of 6.48%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 519 million yuan, a year-on-year decrease of 6.56%. The basic earnings per share were 0.3297 yuan
